| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | -0.049 | 0.2 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.044 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.25 | 0.2 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.21 | 0.2 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.056 | 0.2 |
| mRNA | isoliquiritigenin | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | Pazopanib | GDSC1000 | pan-cancer | AAC | -0.048 | 0.2 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |